Global Biosimilars Market Report 2023-2028: Reimbursement and Payer Landscape Influence Biosimilar Adoption

News provided by

Dec 04, 2023, 11:15 ET

DUBLIN, Dec. 4, 2023 /PRNewswire/ -- The "Growth Opportunities in Global Biosimilars Market, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

This study presents overall market and segment-wise revenue forecasts for the global biosimilars market. It highlights key growth opportunities for biosimilar market participants based on the trends, evolution of business models, and strategic imperatives for various stakeholders. It identifies the greatest revenue-generating therapeutic areas and product types.

Biosimilar acceptance and use are increasing as patients and healthcare providers improve their understanding and awareness of therapeutic agents driven by biosimilar manufacturers and regulators. As the availability of information and practical data supporting the safety and effectiveness of biosimilars increases, both patients and healthcare professionals are developing a greater level of confidence in these medications.

It is imperative for pharmaceutical companies to delicately navigate the intricate balance between safeguarding their biologic products and cultivating an environment conducive to the presence of biosimilars, which inevitably contribute to a thriving competitive milieu.

The elements affecting regional biosimilar uptake and biosimilar market entrance have been clearly stated. In addition, this report covers complicated factors, including reimbursement and payer landscape, biosimilar price trends, and biosimilar sales trends that will affect biosimilar penetration. The study discusses regional biosimilar discrepancies as well as industry issues, including physician adoption and patent litigations.

This report identifies key growth opportunities to increase biosimilar uptake and innovations and compete for newer therapy areas, such as neurology and oncology.

Key Topics Covered:

1. Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative
The Impact of the Top 3 Strategic Imperatives on the Global Biosimilars Market
Growth Opportunities Fuel the Growth Pipeline Engine

2. Growth Opportunity Analysis

Scope of Analysis
Market Segmentation
Key Regional Competitors in the Biosimilars Market
Growth Drivers
Growth Restraints

3. Growth Environment - Biosimilars Market

Highlights - Biosimilars Regional Dynamics
Growth Opportunities - Biosimilars Market
Strategies to Boost Biosimilars Development and Adoption
Biopharma Taking Lead to Boost Adoption of Biosimilars - Sandoz
North America Competitive Benchmarking - Key Countries
Market Snapshot - US Biosimilar Market
Biosimilars Approved in the US
The US Healthcare Financial and Distribution Pathways
Business Model Transformation due to the Next Wave of Biosimilars
Evolving Roles of PBM Formularies to Boost Biosimilar Accessibility
Evolving US Biosimilar Regulatory Landscape
US Insulin Biosimilar Market Set for Major Reset in Response to IRA
Dual Pricing Strategy in the US
US Oncology
US Oncology Supportive Care
US Immunology and Ophthalmology
Europe Competitive Benchmarking - Key Countries
Market Snapshot - Europe Biosimilars Market
Biosimilars Approved in Europe
Swift and Rapid Adoption of Biosimilar - Denmark Success Story
Incentives Driving Adoption of Biosimilars
APAC and MEA Competitive Benchmarking - Key Countries
Market Snapshot - Key APAC and MEA Biosimilar Market
Intensifying Focus of Asian Biopharma and CDMO on the Global Market

4. Growth Opportunity Analysis - Biosimilars Industry

Key Growth Metrics
Forecast Assumptions and Considerations - Biosimilars Market
Revenue Forecast - Global Biosimilars Market
Revenue Forecast Analysis - Global Biosimilars Market
Revenue Forecast by Product Type
Revenue Forecast Analysis by Product Type
Revenue Forecast by Therapeutic Area
New and Upcoming Key Biologics Patent Expiration
Revenue Forecast Analysis - Oncology
Revenue Forecast Analysis - Musculoskeletal and Immunology
Revenue Forecast Analysis - Endocrinology and Ophthalmology
Competitive Environment
Revenue share
Revenue Share Analysis

5. Growth Opportunity Universe

Growth Opportunity 1: RWE Solutions
Growth Opportunity 2: Neurology Biosimilars
Growth Opportunity 3: Focus on the Middle East and Africa
Growth Opportunity 4: Leveraging AI, PD, and Omics Biomarkers
Growth Opportunity 5: Alternative Formulation Methodology for mAb Biosimilars

For more information about this report visit https://www.researchandmarkets.com/r/uhgwoc

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets